Subscribe

Dongyue Group Limited (0189.HK)

HKD13.79 +0.32 (+2.38%)
CN HKSE Basic Materials Chemicals
Address Dongyue International Fluoro
Zibo, CN
CEO Jianhong Zhang
Website dongyuechem.com
IPO 2007-12-10
ISIN KYG2816P1072

Explore sections of this company profile

Description

Dongyue Group Limited functions as an investment holding company, primarily engaged in the production, distribution, and sale of a diverse range of chemical substances. Operating predominantly within the People's Republic of China, its core product offerings include polymers, organic silicones, refrigerants, and industrial chemicals such as dichloromethane, polyvinyl chloride (PVC), and liquid alkali. The company's operations are segmented into distinct divisions: Polymers, Refrigerants, Organic Silicone, Dichloromethane/PVC and Liquid Alkali, Property Development, and Other Operations. Its comprehensive chemical portfolio extends to fluoride fine chemicals, various chloride and alkali compounds, fluoride salt and acid products, polytetrafluoroethylene, methane chloride, anhydrous fluoride, fluorite, silicon rubber, fluoropolymers, ammonium bifluoride, hydrofluoric acid, and bromine derivatives. Beyond its core chemical manufacturing, Dongyue also participates in residential property development and provides environmental services, specifically sewage treatment and monitoring. While its headquarters are located in Zibo, People's Republic of China (where it was established in 1987), the Group maintains a significant international footprint, conducting business across numerous countries including Japan, South Korea, India, Singapore, Thailand, the United Arab Emirates, Pakistan, Malaysia, Kuwait, Saudi Arabia, Indonesia, Israel, the Philippines, Vietnam, and Turkey, among other global markets.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
HKD13.79 +0.32 (+2.38%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
42M
Beta
1.32
Float Shares
932.69M
Free Float %
54.5%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-8.56% +37.43% +25.31% +16.38% +50.05% +51.02% +76.65% +131.12% +161.86% +1,092.70% +760.00%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
13.79
DCF (Unlevered) 3.98 -71.2%
DCF (Levered) 7.56 -45.2%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 4 -3
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
5.93
Safe zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
1 / 10
No MOAT
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Chemicals: +4.0%
    +1.2% Q4'25: -5.5% (vs Q4'23)
  • ✓
    EPS growth Chemicals: +11.7%
    +113.0% ★ Q4'25: +168.4% (vs Q4'23)
  • ✓
    FCF margin FCF growth · Chemicals: +41.7%
    +12.9% ★ Q4'25: +17.4% (vs Q4'23)
  • ✗
    EBIT margin Chemicals: +7.1%
    +15.8% ★ Q4'25: +14.6% (vs Q4'23)
  • ✗
    ROIC Chemicals: +3.4%
    +12.7% ★ Q4'25: +25.8% (vs Q4'23)
  • ✓
    Share dilution Chemicals: +0.0%
    -4.1% ★ Q4'25: -22.4% (vs Q4'23)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×
    0.01× ★ Q4'25: 0.00× (vs Q4'23)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.26) × ERP
WACC = 100% × Ke + 0% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 3.98 Current price: 13.79
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2015
actual 		Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
4 Rev. Ana.
4 EPS Ana. 		Dec 2027
4 Rev. Ana.
4 EPS Ana. 		Dec 2028
2 Rev. Ana.
3 EPS Ana.
Revenue
7.03B
est: 9.65B (-27.1%)
7.97B
est: 9.70B (-17.8%)
10.14B
est: 11.87B (-14.6%)
14.22B
est: 15.76B (-9.8%)
12.96B
est: 13.84B (-6.3%)
10.04B
est: 13.48B (-25.5%)
15.84B
est: 18.65B (-15.0%)
20.03B
est: 18.73B (+6.9%)
14.49B
est: 15.33B (-5.5%)
14.18B
est: 15.88B (-10.7%)
14.36B
est: 15.28B (-6.0%)
16.80B
15.93B – 18.82B
+10.0% YoY
18.00B
16.43B – 20.28B
+7.1% YoY
19.05B
17.72B – 21.40B
+5.8% YoY
EBITDA
1.23B
est: 1.78B (-31.2%)
1.61B
est: 1.79B (-10.5%)
2.69B
est: 2.20B (+22.5%)
3.86B
est: 2.92B (+32.6%)
2.67B
est: 2.56B (+4.4%)
1.58B
est: 2.49B (-36.5%)
3.81B
est: 3.45B (+10.4%)
4.62B
est: 3.46B (+33.2%)
1.87B
est: 2.84B (-34.1%)
2.37B
est: 3.23B (-26.5%)
3.59B
est: 3.11B (+15.6%)
3.42B
3.24B – 3.83B
+10.0% YoY
3.66B
3.34B – 4.13B
+7.1% YoY
3.88B
3.61B – 4.36B
+5.8% YoY
EBIT
546.77M
est: 1.17B (-53.2%)
896.44M
est: 1.17B (-23.6%)
1.98B
est: 1.44B (+38.0%)
3.21B
est: 1.91B (+68.5%)
2.08B
est: 1.67B (+24.4%)
943.60M
est: 1.63B (-42.1%)
3.13B
est: 2.26B (+38.7%)
3.71B
est: 2.27B (+63.7%)
654.83M
est: 1.85B (-64.7%)
1.19B
est: 2.12B (-44.1%)
2.27B
est: 2.04B (+10.9%)
2.25B
2.13B – 2.52B
+10.0% YoY
2.41B
2.20B – 2.71B
+7.1% YoY
2.55B
2.37B – 2.86B
+5.8% YoY
Net Income
-690.48M
est: 684.36M (-200.9%)
588.15M
est: 767.53M (-23.4%)
1.60B
est: 1.61B (-0.8%)
2.13B
est: 2.19B (-2.8%)
1.46B
est: 1.48B (-1.5%)
772.17M
est: 952.52M (-18.9%)
2.07B
est: 2.23B (-6.8%)
3.86B
est: 2.93B (+31.8%)
707.79M
est: 493.24M (+43.5%)
810.80M
est: 862.68M (-6.0%)
1.64B
est: 1.78B (-7.8%)
2.40B
2.28B – 2.60B
+34.7% YoY
2.85B
2.54B – 3.13B
+18.7% YoY
3.17B
2.89B – 3.68B
+11.4% YoY
SGA
512.40M
est: 745.22M (-31.2%)
670.67M
est: 749.19M (-10.5%)
970.29M
est: 916.69M (+5.8%)
1.14B
est: 1.22B (-6.2%)
1.03B
est: 1.07B (-3.2%)
710.53M
est: 1.04B (-31.7%)
1.25B
est: 1.44B (-13.2%)
1.49B
est: 1.45B (+3.2%)
1.15B
est: 1.18B (-2.8%)
1.17B
est: 1.30B (-10.2%)
1.37B
est: 1.26B (+9.2%)
1.38B
1.31B – 1.55B
+10.0% YoY
1.48B
1.35B – 1.67B
+7.1% YoY
1.57B
1.46B – 1.76B
+5.8% YoY
EPS
-0.33
est: 0.39 (-184.2%)
0.28
est: 0.44 (-36.3%)
0.76
est: 0.92 (-17.8%)
1.01
est: 1.25 (-19.5%)
0.70
est: 0.85 (-17.7%)
0.37
est: 0.55 (-32.2%)
0.98
est: 1.27 (-23.1%)
1.73
est: 1.68 (+3.3%)
0.32
est: 0.28 (+13.3%)
0.46
est: 0.51 (-10.6%)
0.98
est: 1.06 (-7.8%)
1.43
1.36 – 1.55
+34.7% YoY
1.70
1.52 – 1.87
+18.7% YoY
1.89
1.72 – 2.20
+11.4% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 A 4/5 4/5 4/5 5/5 3/5 3/5 4/5
2026-05-28 A 4/5 4/5 4/5 5/5 3/5 3/5 4/5
2026-05-27 A 4/5 4/5 4/5 5/5 3/5 3/5 4/5
2026-05-26 A 4/5 4/5 4/5 5/5 3/5 3/5 4/5
2026-05-22 A 4/5 4/5 4/5 5/5 3/5 3/5 4/5
2026-05-21 A 4/5 4/5 4/5 5/5 3/5 3/5 4/5
2026-05-20 A 4/5 4/5 4/5 5/5 3/5 3/5 4/5
2026-05-19 A 4/5 4/5 4/5 5/5 3/5 3/5 4/5
2026-05-18 A 4/5 4/5 4/5 5/5 3/5 3/5 4/5
2026-05-15 A 4/5 4/5 4/5 5/5 3/5 3/5 4/5
2026-05-14 A 4/5 4/5 4/5 5/5 3/5 3/5 4/5
2026-05-13 A 4/5 4/5 4/5 5/5 3/5 3/5 4/5
2026-05-12 A 4/5 4/5 4/5 5/5 3/5 3/5 4/5
2026-05-11 A 4/5 4/5 4/5 5/5 3/5 3/5 4/5
2026-05-08 A 4/5 4/5 4/5 5/5 3/5 3/5 4/5
2026-05-07 A 4/5 4/5 4/5 5/5 3/5 3/5 4/5
2026-05-06 A 4/5 4/5 4/5 5/5 3/5 3/5 4/5
2026-05-05 A 4/5 4/5 4/5 5/5 3/5 3/5 4/5
2026-05-04 A 4/5 4/5 4/5 5/5 3/5 3/5 4/5
2026-04-30 A 4/5 4/5 4/5 5/5 2/5 3/5 4/5
2026-04-29 A 4/5 4/5 4/5 5/5 2/5 3/5 4/5
2026-04-28 A 4/5 4/5 4/5 5/5 2/5 3/5 4/5
2026-04-27 A 4/5 4/5 4/5 5/5 2/5 3/5 4/5
2026-04-24 A 4/5 4/5 4/5 5/5 2/5 3/5 4/5
2026-04-23 A 4/5 4/5 4/5 5/5 2/5 3/5 4/5
2026-04-22 A 4/5 4/5 4/5 5/5 2/5 3/5 4/5
2026-04-21 A 4/5 4/5 4/5 5/5 2/5 3/5 4/5
2026-04-20 A 4/5 4/5 4/5 5/5 2/5 3/5 4/5
2026-04-17 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-16 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-15 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-2.26B
OE per share TTM
-1.27
Owner's Yield
-8.17%
Maintenance CapEx ratio
146.17%
Maint CapEx / Avg PPE
71.4%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
327.5K
Shares Outstanding
1.71B

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Jianhong Zhang Chief Executive Officer & Chairman 7M male
Weidong Wang President & Executive Director 7M male
Zhefeng Zhang Chief Financial Officer, Vice President & Executive Director 6M male
Tak Lai Chung Company Secretary & Executive Director 1M female
Xiuyuan Yu Chief Engineer and Head of Technology Department — male
Yuwen Deputy President — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Chemicals